Evidence map›Paper›PMID 30450527›Full record

ArticleHuman genetics2018

Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.

Davor Lessel, Ayse Bilge Ozel, Susan E Campbell, Abdelkrim Saadi, Martin F Arlt, Keisha Melodi McSweeney, Vasilica Plaiasu, Katalin Szakszon, Anna Szőllős, Cristina Rusu and 10 more

Open access · greenAbstract read
In one paragraph

Article in Human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Lipodystrophies-Disorders of the Fatty Tissue.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Hereditary Syndromes with Signs of Premature Aging.Deutsches Arzteblatt international · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 6 countries.

Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. d.lessel@uke.de.ORCID http://orcid.org/0000-0003-4496-244X
Ayse Bilge OzelDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Susan E CampbellCenter for Gerontology and Healthcare Research, Brown University, Providence, RI, USA.
Abdelkrim SaadiService de neurologie, CHU Ben Aknoun Alger, 2 route des deux Bassins, BenAknoun,, Algers, Algeria.
Martin F ArltDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Keisha Melodi McSweeneyOak Ridge Institute for Science and Education, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, 20993, Silver Spring, MD, USA.
Vasilica PlaiasuRegional Center of Medical Genetics, Alessandrescu-Rusescu INSMC, Bucharest, Romania.
Katalin SzakszonDepartment of Pediatrics, University of Debrecen, Debrecen, Hungary.
Anna SzőllősDepartment of Pediatrics, University of Debrecen, Debrecen, Hungary.
Cristina RusuDepartment of Genetics, University Hospital Iasi, Iasi, Romania.
Armando J RojasInstituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Jaime Lopez-ValdezDepartment of Genetics, Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico.
Holger ThieleCologne Center for Genomics, University of Cologne, Cologne, Germany.
Peter NürnbergCologne Center for Genomics, University of Cologne, Cologne, Germany.
Deborah A NickersonDepartment of Genome Sciences, University of Washington, Seattle, USA.
Michael J BamshadDepartment of Genome Sciences, University of Washington, Seattle, USA.
Jun Z LiDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Thomas W GloverDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Leslie B GordonWarren Alpert Medical School of Brown University, Providence, RI, USA.
University of Michigan · USBrown University · USUniversität Hamburg · DEUniversity of Cologne · DEUniversity of Debrecen · HUUniversity of Washington · USCenter for Drug Evaluation and Research · USCentre Hospitalo-Universitaire Bab El Oued · DZInstitutul National pentru Sanatatea Mamei si Copilului "Alessandrescu-Rusescu" · ROPontificia Universidad Javeriana · CO

Funding

UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
National Human Genome Research Institute 2UM1HG006493NHGRI NIH HHS UM1 HG006493NIGMS NIH HHS R25 GM086262Universität Hamburg NWF 17/06/2-1
6 · The paper itself

Abstract

Juvenile segmental progeroid syndromes are rare, heterogeneous disorders characterized by signs of premature aging affecting more than one tissue or organ starting in childhood. Hutchinson-Gilford progeria syndrome (HGPS), caused by a recurrent de novo synonymous LMNA mutation resulting in aberrant splicing and generation of a mutant product called progerin, is a prototypical example of such disorders. Here, we performed a joint collaborative study using massively parallel sequencing and targeted Sanger sequencing, aimed at delineating the underlying genetic cause of 14 previously undiagnosed, clinically heterogeneous, non-LMNA-associated juvenile progeroid patients. The molecular diagnosis was achieved in 11 of 14 cases (~ 79%). Furthermore, we firmly establish biallelic mutations in POLR3A as the genetic cause of a recognizable, neonatal, Wiedemann-Rautenstrauch-like progeroid syndrome. Thus, we suggest that POLR3A mutations are causal for a portion of under-diagnosed early-onset segmental progeroid syndromes. We additionally expand the clinical spectrum associated with PYCR1 mutations by showing that they can somewhat resemble HGPS in the first year of life. Moreover, our results lead to clinical reclassification in one single case. Our data emphasize the complex genetic and clinical heterogeneity underlying progeroid disorders.

Indexed as

AdolescentAlternative SplicingChilddelta-1-Pyrroline-5-Carboxylate ReductaseFemaleFetal Growth RetardationGenetic Predisposition to DiseaseHumansInfantLamin Type AMaleMutationPhenotypeProgeriaPyrroline Carboxylate ReductasesRNA Polymerase IIIdelta-1-Pyrroline-5-Carboxylate ReductaseLamin Type ALMNA protein, humanPOLR3A protein, humanprelamin APyrroline Carboxylate ReductasesRNA Polymerase IIIHutchinson–Gilford progeria syndromeJuvenile segmental progeroid syndromePOLR3APYCR1Wiedemann–Rautenstrauch progeroid syndrome

Identifiers

PMID30450527
PMCPMC6652186
OpenAlexW2901020476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.